Skip to main content
Advicenne logo

Advicenne — Investor Relations & Filings

Ticker · ALDVI ISIN · FR0013296746 LEI · 969500YT5VMEYAYODW34 PA Manufacturing
Open in API
Filings indexed 257 across all filing types
Latest filing 2025-06-30 Share Issue/Capital Cha…
Country FR France
Listing PA ALDVI

About Advicenne

https://advicenne.com

Advicenne is a specialty pharmaceutical company dedicated to developing and commercializing treatments for rare renal diseases. The company focuses on addressing unmet medical needs in nephrology for both children and adults. Its lead product, Sibnayal®, is an approved treatment for distal Renal Tubular Acidosis (dRTA). Advicenne is committed to improving the lives of patients with rare kidney conditions by developing therapeutics, including pediatric-friendly formulations, suitable for patients of all ages.

Recent filings

Filing Released Lang Actions
Inside Information / Operations of the issuer (acquisitions, sales...)
Share Issue/Capital Change Classification · 1% confidence The document is a press release from Advicenne detailing a capital increase through a rights issue and a loan restructuring agreement. It provides specific financial terms, subscription ratios, pricing, and the purpose of the capital raise. While it mentions financial outlooks, it is primarily an announcement of a financing event (capital increase) and debt restructuring, which falls under the 'Capital/Financing Update' category.
2025-06-30 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 1% confidence The document is titled "Advicenne annonce l'approbation de l'ensemble des résolutions soutenues par le Conseil d'administration lors de son assemblée générale mixte" (Advicenne announces the approval of all resolutions supported by the Board of Directors at its combined general meeting). It explicitly mentions the date and location of the 'assemblée générale mixte des actionnaires' (combined general meeting of shareholders) and details the results of the votes on various resolutions, including the approval of accounts and delegations. This content directly relates to the proceedings and outcomes of a shareholder meeting. The most specific category for official results from shareholder votes at a general meeting is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it discusses the AGM, the focus is on the voting results, not the presentation materials (AGM-R) or the proxy solicitation (PSI).
2025-05-16 French
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel
Report Publication Announcement Classification · 1% confidence The document is a press release dated April 29, 2025, announcing that Advicenne has made its 'Document d'Enregistrement Universel 2024' (Universal Registration Document 2024) available to the AMF (Autorité des Marchés Financiers). The text explicitly states that this document includes the annual report, management report, and governance report, and it provides links where the document can be accessed. Since the document itself is an announcement about the publication of a major annual filing (which contains the 10-K equivalent information), and given its short length (3964 chars), it fits the definition of a Report Publication Announcement (RPA) rather than the comprehensive report itself (10-K or AR).
2025-04-29 French
Annual financial and audit reports / Terms of availability of the annual financial report
Report Publication Announcement Classification · 1% confidence The document is a press release dated April 29, 2025, announcing that the '2024 Universal Registration Document' has been filed with the AMF (French regulator). The text explicitly states that the Universal Registration Document *includes* the annual report, management report, governance report, and statutory auditors' reports. Crucially, the document itself is short (3007 characters) and its primary function is to announce the availability/filing of a larger report, rather than being the report itself. According to Rule #2 (The 'MENU VS MEAL' Rule), when a document announces the publication of a report, it should be classified as a Report Publication Announcement (RPA).
2025-04-29 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 1% confidence The document is titled with a summary of the 2024 performance, including key financial metrics (revenue, cash burn, cash position) and operational highlights (Sibnayal sales, US regulatory progress). It explicitly states, "Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce aujourd'hui ses résultats financiers annuels 2024 et fait le point sur ses activités." It contains detailed financial tables comparing 2024 to 2023 results, covering income statement and cash flow items. Although it mentions that the full accounts will be in the 'Document d'Enregistrement Universel 2024' (which often corresponds to a 10-K equivalent in structure or content), the document itself is a comprehensive annual financial results announcement, which aligns best with the 'Annual Report' category (10-K) or potentially an 'Interim/Quarterly Report' (IR) if it were not annual. Since it covers the full fiscal year 2024 and provides detailed financial statements and management discussion, it functions as the primary annual financial disclosure, making 10-K the most appropriate classification, even if it's a French company's equivalent disclosure format. It is not merely an Earnings Release (ER) because it is highly detailed and includes full financial tables, nor is it just a Report Publication Announcement (RPA) as it contains the substance of the results, not just a notice of publication. Given the comprehensive nature covering the full year, 10-K is selected. FY 2024
2025-03-27 French
Inside Information / News release on accounts, results
Earnings Release Classification · 1% confidence The document is explicitly titled as an announcement of the '2024 financial results, and provides an update on its activities' released on March 27, 2025. It contains key financial highlights, a summary table of results, commentary from the CEO, and future outlook. This structure, focusing on the immediate release of period-end financial performance figures (2024 results), strongly indicates an Earnings Release (ER). While it mentions that the full financial statements will be available later in the Universal Registration Document (which might contain the full 10-K equivalent data), this specific document serves as the initial, high-level announcement of the results. FY 2024
2025-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.